Novel Biomarker-Guided Treatment: PSMA, PAR, HDACs, etc.
Dr. Daniel P. Petrylak presented “Novel Biomarker-Guided Treatment: PSMA, PAR, HDACs,...
Read MoreSelect Page
Posted by Daniel P. Petrylak, MD | Apr 2017
Dr. Daniel P. Petrylak presented “Novel Biomarker-Guided Treatment: PSMA, PAR, HDACs,...
Read MorePosted by Raoul S. Concepcion, MD, FACS | Apr 2017
Dr. Raoul S. Concepcion presented “Targeting AR in Castration-Resistant Prostate...
Read MorePosted by Jehonathan H. Pinthus, MD, PhD, FRCSC | Apr 2017
Dr. Jehonathan Pinthus presented “Neuroendocrine Prostate Cancer (NEPC)” at the 27th...
Read MorePosted by Thomas E. Keane, MD | Apr 2017
Dr. Thomas E. Keane presented “New Concepts in Androgen Deprivation Therapy” at the...
Read MorePosted by Daniel P. Petrylak, MD | Apr 2017
Dr. Daniel P. Petrylak and Dr. Michael S. Cookson presented “Point-Counterpoint: Early...
Read More